What happened
Telcon RF Pharmaceutical disclosed a supply contract with KT Corp., worth US$1.72M, about 5.34% of its recent annual revenue, running through Sep 2027.
For context, this single contract equals about 5.34% of the company's most recent annual revenue.
| Counterparty | KT Corp. |
|---|---|
| Contract value | US$1.72M |
| vs. recent revenue | 5.34% |
| Through | Sep 2027 (from Oct 2026) |
| Filed | 2026-10-02, Supply contract signed (voluntary) |
| Source | DART rcept 20261002900462 → open original filing |
Source: DART. Information only, not investment advice.